Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in
Western countries and affects approximately 25% of the adult population. Since NAFLD is …

The ongoing obesity epidemic represents a global public health crisis that contributes to
poor health outcomes, reduced quality of life, and> 2.8 million deaths each year. Obesity is …

Recent advances have greatly improved our understanding of the molecular mechanisms
behind atherosclerosis pathogenesis. However, there is still a need to systematize this data …

Aims We tested the hypothesis that the contrasting results for the effect of high-dose, purified
omega-3 fatty acids on the prevention of atherosclerotic cardiovascular disease (ASCVD) in …

Current algorithms for assessing risk of atherosclerotic cardiovascular disease (ASCVD)
and, in particular, the reliance on low-density lipoprotein (LDL) cholesterol in conditions …

Despite considerable advances in reducing the global burden of atherosclerotic
cardiovascular disease by targeting conventional risk factors, significant residual risk …

Atherosclerotic cardiovascular disease (ASCVD) is epidemic throughout the world and is
etiologic for such acute cardiovascular events as myocardial infarction, ischemic stroke …

Background: Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high
triglyceride levels together with low HDL and normal or high LDL cholesterol and are …

Atherosclerosis is one of the most fatal diseases in the world. The associated thickening of
the arterial wall and its background and consequences make it a very composite disease …

The emerging issues nowadays are non-alcoholic fatty liver disease (NAFLD) and its
advanced stage non-alcoholic steatohepatitis (NASH), which further can be a predisposing …